Making sense of it all

It’s been almost two full weeks since the ADA conference ended and we’re still trying to make sense of it all. What’s pretty obvious is that Dexcom up 10.6% and Insulet up 5.3% were the big winners in terms of stock price appreciation. Everyone else has basically tread water.

Everyone seems to think its big news that Dexcom intimated but did not come right out and state that their sensor will send readings directly to the Apple Watch. Everyone but us that is for what have we been saying consistently Apple and Dexcom are . . .

This content is restricted to subscribers. Please subscribe.

Already have an account? Please login.

© 2005 - 2019 Diabetic Investor, Inc., all rights reserved. Unless expressly permitted under your written license agreement, you are not authorized to forward or to otherwise copy our newsletter, or any portion thereof, by electronic means or otherwise. 17 U.S.C. §504 provides for statutory damages of up to $150,000 per infringement of a copyright and additional damages.